These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29721568)
1. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor. Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568 [TBL] [Abstract][Full Text] [Related]
2. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation. Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152 [TBL] [Abstract][Full Text] [Related]
3. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor. Wang J; Fu T; Dong R; Wang C; Liu K; Sun H; Huo X; Ma X; Yang X; Meng Q Food Funct; 2019 Jul; 10(7):3839-3850. PubMed ID: 31210195 [TBL] [Abstract][Full Text] [Related]
4. Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury. Gao X; Fu T; Wang C; Ning C; Kong Y; Liu Z; Sun H; Ma X; Liu K; Meng Q Biochem Pharmacol; 2017 Dec; 146():127-138. PubMed ID: 28987596 [TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice. Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663 [TBL] [Abstract][Full Text] [Related]
6. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis. Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198 [TBL] [Abstract][Full Text] [Related]
7. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro. Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435 [TBL] [Abstract][Full Text] [Related]
8. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2. Liu B; Li Y; Ji H; Lu H; Li H; Shi Y Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury. Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225 [TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction. Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916 [TBL] [Abstract][Full Text] [Related]
11. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375 [TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages. Lee HS; Shin HS; Choi J; Bae SJ; Wee HJ; Son T; Seo JH; Park JH; Kim SW; Kim KW Int J Oncol; 2016 Oct; 49(4):1407-14. PubMed ID: 27498767 [TBL] [Abstract][Full Text] [Related]
13. Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury. Zhou Y; Li M; Cao Y; Chang W; Jia H; Wang L; Xu H; Wang Y; Liu P; Chen WD Int Immunopharmacol; 2024 Sep; 139():112799. PubMed ID: 39068755 [TBL] [Abstract][Full Text] [Related]
14. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway. Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity. Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579 [TBL] [Abstract][Full Text] [Related]
16. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130 [TBL] [Abstract][Full Text] [Related]
17. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605 [TBL] [Abstract][Full Text] [Related]
18. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand. Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598 [TBL] [Abstract][Full Text] [Related]
19. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
20. Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling. Jiang YC; Dou JY; Xuan MY; Gao C; Li ZX; Lian LH; Cui ZY; Nan JX; Wu YL J Agric Food Chem; 2024 Jul; 72(28):15740-15754. PubMed ID: 38970822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]